Information for Health Professionals
MigraPure has been tested in a double-blind, placebo-controlled clinical trial conducted by three top headache experts with results published in top-tier medical journals.
High efficacy rates for migraine relief and associated symptoms
An excellent safety profile
MigraPure provides a side-effect profile similar to placebo
MigraPure was well tolerated and no serious adverse events were reported
MigraPure was Clinically Tested The results authored by Dr. Roger Cady and Dr. Jerome Goldstein and Dr. Robert Nett, et al, with results published in: A Double-Blind Placebo-Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesic M*) in the Treatment of Migraines in Headache: The Journal of Head and Face Pain, 2011: 51:1078-1086
HOW IT WORKS
Sublingual administration allows the immediate absorption of full-strength active ingredients through the capillaries under the tongue. Users report that relief often starts in minutes.
Sublingual delivery is efficient and superior because:
It is up to 60% faster than pills
Avoids the “first pass” breakdown of active ingredients digested by the stomach and liver
You should not take MigraPure® if:
You are pregnant or breast feeding
If you have a known allergy to any of the ingredients